Technology
The director of Overwatch is leaving Blizzard – Yahoo Finance Australia
After nearly two decades at the company, one of Blizzard’s best-known employees is ready for something new.
Opening of Investigational New Drug Application (IND) with U.S. Food and Drug Administration (FDA) for Phase III study of nomacopan in bullous pemphigoid (BP), a severe dermatological disease with no specific approved treatments Phase III study in severe pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) is open for enrollment in the U.S. and Europe New data supports potential for nomacopan as a treatment for dry age-related macular degeneration (AMD), a sight-threatening…
-
General15 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Noosa News17 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business15 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General17 hours agoToo skewed, too gentlemanly | The Spectator Australia